David P. Carbone

机构：The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University · ORCID：0000-0003-3002-1921

发表论文 979 篇 · 总被引 46577 次 · h-index 98

代表论文

• PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation (2025 · Journal of Clinical Investigation · 被引 5)
• Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer (2025 · Investigational New Drugs · 被引 2)
• Employment of artificial intelligence for early lung cancer diagnosis: a retrospective cohort study (2025 · BMJ Open Respiratory Research · 被引 2)
• Supplementary Data 1 from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (2026)
• Data from Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab–Based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer (2026)
• Supplementary Figure 1 from Dietary and Lifestyle Patterns among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes (2026)